ProMetic BioSciences, Inc. Concludes Manufacture And Supply Agreements With Novozymes Delta Limited  
10/4/2006 1:05:28 PM

MONTREAL, QUEBEC -- (MARKET WIRE) -- October 04, 2006 -- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") is pleased to announce the completion of long-term manufacture and supply agreements for two synthetic-ligand affinity adsorbent products manufactured by its U.K. subsidiary ProMetic Biosciences Ltd ("PBL") and used by Novozymes Delta Ltd ("Delta") for the manufacture of Recombumin®. The agreements provide commercial terms for the supply of process-scale quantities of both products for an initial 10-year term with the option of subsequent renewal periods.